The DOI matches its Crossref record; 225 of the 225 references it cites were found in a registry or an index.
Current insights into the regulation of programmed cell death by NF-κB
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: KSHV vFLIP Is Essential for the Survival of Infected Lymphoma Cells
Guasparri, I., Keller, S. A., & Cesarman, E. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031467 · Cited by 324
RetractedDistinct types of diffuse large B-cell lymphoma identified by gene expression profiling
Alizadeh, A. A., Eisen, M. B., Davis, R. E., Ma, C., Lossos, I. S., Rosenwald, A., Boldrick, J. C., Sabet, H., Tran, T., Yu, X., et al. (2000) · Nature · doi:10.1038/35000501 · Cited by 9,925
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
Dong, H., Strome, S. E., Salomao, D. R., Tamura, H., Hirano, F., Flies, D. B., Roche, P. C., Lu, J., Zhu, G., Tamada, K., et al. (2002) · Nature Medicine · doi:10.1038/nm730 · Cited by 5,025 · cited 1×
“…death has also been linked to increased expression of the pro-death factors B7-H1 (PCD ligand 1, pdcd1), which induces apoptosis of T lymphocytes (Dong et al., 2002; Yu et al., 2004; Lee et al., 2005), and caspase-11, which can activate the death effector caspase-3 (Kang et al., 2000;…”
BackgroundDanial, N. N., & Korsmeyer, S. J. (2004) · Cell · doi:10.1016/s0092-8674(04)00046-7 · Cited by 4,651
Signal transduction by the JNK group of MAP kinases
Davis, R. J. (2000) · Cell · doi:10.1016/s0092-8674(00)00116-1 · Cited by 4,237
NF-κB regulation in the immune system
Li, Q., & Verma, I. M. (2002) · Nature Reviews Immunology · doi:10.1038/nri910 · Cited by 4,007
Activators and target genes of Rel/NF-κB transcription factors
Pahl, H. L. (1999) · Oncogene · doi:10.1038/sj.onc.1203239 · Cited by 3,727
Activators and Target Genes of Rel/NF-кB Transcription Factors: From Bench to Bedside
Loop, T., & Pahl, H. L. (2003) · Nuclear Factor кB · doi:10.1007/978-94-010-0163-2_1 · Cited by 3,169
An Essential Role for NF-κB in Preventing TNF-α-Induced Cell Death
Beg, A. A., & Baltimore, D. (1996) · Science · doi:10.1126/science.274.5288.782 · Cited by 3,047
Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes
Micheau, O., & Tschopp, J. (2003) · Cell · doi:10.1016/s0092-8674(03)00521-x · Cited by 2,738
Wang, C.-Y., Mayo, M. W., Korneluk, R. G., Goeddel, D. V., & Baldwin, A. S. (1998) · Science · doi:10.1126/science.281.5383.1680 · Cited by 2,711
NF-κB at the crossroads of life and death
Karin, M., & Lin, A. (2002) · Nature Immunology · doi:10.1038/ni0302-221 · Cited by 2,709 · cited 2×
“…Gélinas, 1999; Alizadeh et al., 2000; Cogswell et al., 2000; Kordes et al., 2000; Davis et al., 2001; Hinz et al., 2001; Gilmore et al., 2002; Kalaitzidis et al., 2002; Karin and Lin, 2002; Shipp et al., 2002; Barth et al., 2003; Munzert et al., 2004; Feuerhake et al., 2005; Fan et al., 2006a, b).”
BackgroundHigh-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal
Lotze, M. T., & Tracey, K. J. (2005) · Nature Reviews Immunology · doi:10.1038/nri1594 · Cited by 2,487
NF-κB in cancer: from innocent bystander to major culprit
Karin, M., Cao, Y., Greten, F. R., & Li, Z.-W. (2002) · Nature Reviews Cancer · doi:10.1038/nrc780 · Cited by 2,478
IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
Greten, F. R., Eckmann, L., Greten, T. F., Park, J. M., Li, Z.-W., Egan, L. J., Kagnoff, M. F., & Karin, M. (2004) · Cell · doi:10.1016/j.cell.2004.07.013 · Cited by 2,433
NF-κB functions as a tumour promoter in inflammation-associated cancer
Pikarsky, E., Porat, R. M., Stein, I., Abramovitch, R., Amit, S., Kasem, S., Gutkovich-Pyest, E., Urieli-Shoval, S., Galun, E., & Ben-Neriah, Y. (2004) · Nature · doi:10.1038/nature02924 · Cited by 2,430
Shipp, M. A., Ross, K. N., Tamayo, P., Weng, A. P., Kutok, J. L., Aguiar, R. C. T., Gaasenbeek, M., Angelo, M., Reich, M., Pinkus, G. S., et al. (2002) · Nature Medicine · doi:10.1038/nm0102-68 · Cited by 2,428
De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling
Wertz, I. E., O'Rourke, K. M., Zhou, H., Eby, M., Aravind, L., Seshagiri, S., Wu, P., Wiesmann, C., Baker, R., Boone, D. L., et al. (2004) · Nature · doi:10.1038/nature02794 · Cited by 1,856
Chen, L., Willis, S. N., Wei, A., Smith, B. J., Fletcher, J. I., Hinds, M. G., Colman, P. M., Day, C. L., Adams, J. M., & Huang, D. C. S. (2005) · Molecular Cell · doi:10.1016/j.molcel.2004.12.030 · Cited by 1,816
Kamata, H., Honda, S.-I., Maeda, S., Chang, L., Hirata, H., & Karin, M. (2005) · Cell · doi:10.1016/j.cell.2004.12.041 · Cited by 1,792
Inhibition of NF-κB by Sodium Salicylate and Aspirin
Kopp, E., & Ghosh, S. (1994) · Science · doi:10.1126/science.8052854 · Cited by 1,753
The anti-inflammatory agents aspirin and salicylate inhibit the activity of IκB kinase-β
Yin, M.-J., Yamamoto, Y., & Gaynor, R. B. (1998) · Nature · doi:10.1038/23948 · Cited by 1,590
Four deaths and a funeral: from caspases to alternative mechanisms
Leist, M., & Jäättelä, M. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35085008 · Cited by 1,587
Control of oncogenesis and cancer therapy resistance by the transcription factor NF-κB
Baldwin, A. S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11991 · Cited by 1,434
Requirement for glycogen synthase kinase-3β in cell survival and NF-κB activation
Hoeflich, K. P., Luo, J., Rubie, E. A., Tsao, M.-S., Jin, O., & Woodgett, J. R. (2000) · Nature · doi:10.1038/35017574 · Cited by 1,393
Deveraux, Q. L. (1998) · The EMBO Journal · doi:10.1093/emboj/17.8.2215 · Cited by 1,388
Death by design: apoptosis, necrosis and autophagy
Edinger, A. L., & Thompson, C. B. (2004) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2004.09.011 · Cited by 1,364
A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-γ
Pascual, G., Fong, A. L., Ogawa, S., Gamliel, A., Li, A. C., Perissi, V., Rose, D. W., Willson, T. M., Rosenfeld, M. G., & Glass, C. K. (2005) · Nature · doi:10.1038/nature03988 · Cited by 1,254
Hayden, M. S., West, A. P., & Ghosh, S. (2006) · Oncogene · doi:10.1038/sj.onc.1209943 · Cited by 1,178
Aberrant rel/nfkb genes and activity in human cancer
Rayet, B., & Gélinas, C. (1999) · Oncogene · doi:10.1038/sj.onc.1203221 · Cited by 1,110
Self-citationDavis, R. E., Brown, K. D., Siebenlist, U., & Staudt, L. M. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.12.1861 · Cited by 1,051
The tumour suppressor CYLD negatively regulates NF-κB signalling by deubiquitination
Kovalenko, A., Chable-Bessia, C., Cantarella, G., Israël, A., Wallach, D., & Courtois, G. (2003) · Nature · doi:10.1038/nature01802 · Cited by 1,016
Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes
Listen, P., Roy, N., Tamai, K., Lefebvre, C., Baird, S., Cherton-Horvat, G., Farahani, R., McLean, M., lkeda, J.-E., Mackenzie, A., et al. (1996) · Nature · doi:10.1038/379349a0 · Cited by 1,014
Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-κB
Brummelkamp, T. R., Nijman, S. M. B., Dirac, A. M. G., & Bernards, R. (2003) · Nature · doi:10.1038/nature01811 · Cited by 952
NF-κB in neuronal plasticity and neurodegenerative disorders
Mattson, M. P., & Camandola, S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11916 · Cited by 877 · cited 1×
“Opposite effects of NF-kB, namely either to promote or block apoptosis, have been observed in the nervous system, and the nature of NF-kB’s effect appears to be influenced by the cell type and the death-inducing stimulus (reviewed in Mattson and Camandola, 2001; Kucharczak et al., 2003).”
BackgroundChu, Z.-L., McKinsey, T. A., Liu, L., Gentry, J. J., Malim, M. H., & Ballard, D. W. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.19.10057 · Cited by 872
Shakhov, A. N., Collart, M. A., Vassalli, P., Nedospasov, S. A., & Jongeneel, C. V. (1990) · The Journal of Experimental Medicine · doi:10.1084/jem.171.1.35 · Cited by 819
Constitutive Activation of NF-κB during Progression of Breast Cancer to Hormone-Independent Growth
Nakshatri, H., Bhat-Nakshatri, P., Martin, D. A., Goulet, R. J., & Sledge, G. W. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.7.3629 · Cited by 819
NF-κB Signals Induce the Expression of c-FLIP
Micheau, O., Lens, S., Gaide, O., Alevizopoulos, K., & Tschopp, J. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.16.5299-5305.2001 · Cited by 813
To be, or not to be: NF-κB is the answer – role of Rel/NF-κB in the regulation of apoptosis
Kucharczak, J., Simmons, M. J., Fan, Y., & Gélinas, C. (2003) · Oncogene · doi:10.1038/sj.onc.1207230 · Cited by 769
Self-citationBargou, R. C., Emmerich, F., Krappmann, D., Bommert, K., Mapara, M. Y., Arnold, W., Royer, H. D., Grinstein, E., Greiner, A., Scheidereit, C., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119849 · Cited by 761
The Rel/NF-κB Family Directly Activates Expression of the Apoptosis Inhibitor Bcl-x L
Chen, C., Edelstein, L. C., & Gélinas, C. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.8.2687-2695.2000 · Cited by 760
Self-citationHu, P., Han, Z., Couvillon, A. D., Kaufman, R. J., & Exton, J. H. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.8.3071-3084.2006 · Cited by 754
Induction of gadd45β by NF-κB downregulates pro-apoptotic JNK signalling
De Smaele, E., Zazzeroni, F., Papa, S., Nguyen, D. U., Jin, R., Jones, J., Cong, R., & Franzoso, G. (2001) · Nature · doi:10.1038/35104560 · Cited by 732 · cited 1×
“Myd118/GADD45b can oppose JNK signaling by blocking the activity of the JNK-activating kinase MKK7/JNKK2, hence suppressing cell death (De Smaele et al., 2001; Papa et al., 2004a, b), although gadd45b-deficient mice do not show persistent activation of JNK akin to those lacking xiap (Harlin et al.,…”
BackgroundNuclear factor-κB inhibitors as sensitizers to anticancer drugs
Nakanishi, C., & Toi, M. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1588 · Cited by 724
Kasibhatla, S., Brunner, T., Genestier, L., Echeverri, F., Mahboubi, A., & Green, D. R. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80054-4 · Cited by 721
Inhibition of JNK activation through NF-κB target genes
Tang, G., Minemoto, Y., Dibling, B., Purcell, N. H., Li, Z., Karin, M., & Lin, A. (2001) · Nature · doi:10.1038/35104568 · Cited by 721
Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer.
Sovak, M. A., Bellas, R. E., Kim, D. W., Zanieski, G. J., Rogers, A. E., Traish, A. M., & Sonenshein, G. E. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119848 · Cited by 720
Zong, W.-X., Edelstein, L. C., Chen, C., Bash, J., & Gelinas, C. (1999) · Genes & Development · doi:10.1101/gad.13.4.382 · Cited by 720
Chang, L., Kamata, H., Solinas, G., Luo, J.-L., Maeda, S., Venuprasad, K., Liu, Y.-C., & Karin, M. (2006) · Cell · doi:10.1016/j.cell.2006.01.021 · Cited by 706
NF-κB functions in synaptic signaling and behavior
Meffert, M. K., Chang, J. M., Wiltgen, B. J., Fanselow, M. S., & Baltimore, D. (2003) · Nature Neuroscience · doi:10.1038/nn1110 · Cited by 690
Nuclear factor-κB and inhibitor of κB kinase pathways in oncogenic initiation and progression
Bassères, D. S., & Baldwin, A. S. (2006) · Oncogene · doi:10.1038/sj.onc.1209942 · Cited by 667
Pham, C. G., Bubici, C., Zazzeroni, F., Papa, S., Jones, J., Alvarez, K., Jayawardena, S., De Smaele, E., Cong, R., Beaumont, C., et al. (2004) · Cell · doi:10.1016/j.cell.2004.10.017 · Cited by 663
IκB kinase complexes: gateways to NF-κB activation and transcription
Scheidereit, C. (2006) · Oncogene · doi:10.1038/sj.onc.1209934 · Cited by 651
Ryo, A., Suizu, F., Yoshida, Y., Perrem, K., Liou, Y.-C., Wulf, G., Rottapel, R., Yamaoka, S., & Lu, K. P. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00490-8 · Cited by 637
Stehlik, C., de Martin, R., Kumabashiri, I., Schmid, J. A., Binder, B. R., & Lipp, J. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.1.211 · Cited by 635
Hostile takeovers: viral appropriation of the NF-kB pathway
Hiscott, J., Kwon, H., & Génin, P. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11918 · Cited by 613
A Single BIR Domain of XIAP Sufficient for Inhibiting Caspases
Takahashi, R., Deveraux, Q., Tamm, I., Welsh, K., Assa-Munt, N., Salvesen, G. S., & Reed, J. C. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.14.7787 · Cited by 608
A loss-of-function RNA interference screen for molecular targets in cancer
Ngo, V. N., Davis, R. E., Lamy, L., Yu, X., Zhao, H., Lenz, G., Lam, L. T., Dave, S., Yang, L., Powell, J., et al. (2006) · Nature · doi:10.1038/nature04687 · Cited by 605
Roles for NF-κB in nerve cell survival, plasticity, and disease
Mattson, M. P., & Meffert, M. K. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401837 · Cited by 595
Wang, C.-Y., Guttridge, D. C., Mayo, M. W., & Baldwin, A. S. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.9.5923 · Cited by 590
Inhibition of NF-kappaB/Rel induces apoptosis of murine B cells.
Wu, M., Lee, H., Bellas, R. E., Schauer, S. L., Arsura, M., Katz, D., FitzGerald, M. J., Rothstein, T. L., Sherr, D. H., & Sonenshein, G. E. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00845.x · Cited by 587
Brambilla, R., Bracchi-Ricard, V., Hu, W.-H., Frydel, B., Bramwell, A., Karmally, S., Green, E. J., & Bethea, J. R. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041918 · Cited by 586
NF-κB Inducers Upregulate cFLIP, a Cycloheximide-Sensitive Inhibitor of Death Receptor Signaling
Kreuz, S., Siegmund, D., Scheurich, P., & Wajant, H. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.12.3964-3973.2001 · Cited by 583
Embryonic Lethality, Liver Degeneration, and Impaired NF-κB Activation in IKK-β-Deficient Mice
Tanaka, M., Fuentes, M. E., Yamaguchi, K., Durnin, M. H., Dalrymple, S. A., Hardy, K. L., & Goeddel, D. V. (1999) · Immunity · doi:10.1016/s1074-7613(00)80042-4 · Cited by 569
Inhibitors of NF-κB signaling: 785 and counting
Gilmore, T. D., & Herscovitch, M. (2006) · Oncogene · doi:10.1038/sj.onc.1209982 · Cited by 569
Huang, T. T., Wuerzberger-Davis, S. M., Wu, Z.-H., & Miyamoto, S. (2003) · Cell · doi:10.1016/s0092-8674(03)00895-x · Cited by 560
Tamatani, M., Che, Y. H., Matsuzaki, H., Ogawa, S., Okado, H., Miyake, S.-I., Mizuno, T., & Tohyama, M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.13.8531 · Cited by 549
Transcriptional regulation of bcl-2 by nuclear factor κB and its significance in prostate cancer
Catz, S. D., & Johnson, J. L. (2001) · Oncogene · doi:10.1038/sj.onc.1204926 · Cited by 538
NF-κB blockade and oncogenic Ras trigger invasive human epidermal neoplasia
Dajee, M., Lazarov, M., Zhang, J. Y., Cai, T., Green, C. L., Russell, A. J., Marinkovich, M. P., Tao, S., Lin, Q., Kubo, Y., et al. (2003) · Nature · doi:10.1038/nature01283 · Cited by 535
Bcl10 activates the NF-κB pathway through ubiquitination of NEMO
Zhou, H., Wertz, I., O'Rourke, K., Ultsch, M., Seshagiri, S., Eby, M., Xiao, W., & Dixit, V. M. (2004) · Nature · doi:10.1038/nature02273 · Cited by 527
Lee, H. H., Dadgostar, H., Cheng, Q., Shu, J., & Cheng, G. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.16.9136 · Cited by 521
Evidence for the involvement of TNF and NF-?B in hippocampal synaptic plasticity
Albensi, B. C., & Mattson, M. P. (2000) · Synapse · doi:10.1002/(sici)1098-2396(200002)35:2<151::aid-syn8>3.0.co;2-p · Cited by 521
Sakon, S., Xue, X., Takekawa, M., Sasazuki, T., Okazaki, T., Kojima, Y., Piao, J., Yagita, H., Okumura, K., Doi, T., et al. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg379 · Cited by 497
Sulindac Inhibits Activation of the NF-κB Pathway
Yamamoto, Y., Yin, M.-J., Lin, K.-M., & Gaynor, R. B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.38.27307 · Cited by 494
Good cop, bad cop: the different faces of NF-κB
Perkins, N. D., & Gilmore, T. D. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401838 · Cited by 489 · cited 1×
“How some of these agents shift the transactivating property of RelA into that of a promoter-specific transcriptional repressor has recently come to light (Figure 3; reviewed in Perkins and Gilmore, 2006).”
BackgroundSevere liver degeneration and lack of NF-κ B activation in NEMO/IKKγ-deficient mice
Rudolph, D., Yeh, W.-C., Wakeham, A., Rudolph, B., Nallainathan, D., Potter, J., Elia, A. J., & Mak, T. W. (2000) · Genes & Development · doi:10.1101/gad.14.7.854 · Cited by 479
IKK1-deficient mice exhibit abnormal development of skin and skeleton
Li, Q., Lu, Q., Hwang, J. Y., Buscher, D., Lee, K.-F., Izpisua-Belmonte, J. C., & Verma, I. M. (1999) · Genes & Development · doi:10.1101/gad.13.10.1322 · Cited by 469
Cogswell, P. C., Guttridge, D. C., Funkhouser, W. K., & Baldwin, A. S. (2000) · Oncogene · doi:10.1038/sj.onc.1203412 · Cited by 452
Krikos, A., Laherty, C. D., & Dixit, V. M. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)37138-8 · Cited by 444
The inhibitors of apoptosis: there is more to life than Bcl2
Liston, P., Fong, W. G., & Korneluk, R. G. (2003) · Oncogene · doi:10.1038/sj.onc.1207101 · Cited by 440
Seitz, C. S., Lin, Q., Deng, H., & Khavari, P. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.5.2307 · Cited by 436
Requirement for Caspase-8 in NF-κB Activation by Antigen Receptor
Su, H., Bidère, N., Zheng, L., Cubre, A., Sakai, K., Dale, J., Salmena, L., Hakem, R., Straus, S., & Lenardo, M. (2005) · Science · doi:10.1126/science.1104765 · Cited by 429
Characterization of XIAP-Deficient Mice
Harlin, H., Reffey, S. B., Duckett, C. S., Lindsten, T., & Thompson, C. B. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.10.3604-3608.2001 · Cited by 422
Grumont, R. J., Rourke, I. J., & Gerondakis, S. (1999) · Genes & Development · doi:10.1101/gad.13.4.400 · Cited by 403
Bubici, C., Papa, S., Dean, K., & Franzoso, G. (2006) · Oncogene · doi:10.1038/sj.onc.1209936 · Cited by 399
NEW EMBO MEMBER'S REVIEW: NF-kappaB and virus infection: who controls whom
Santoro, M. G. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg267 · Cited by 396
The Human Anti-apoptotic Proteins cIAP1 and cIAP2 Bind but Do Not Inhibit Caspases
Eckelman, B. P., & Salvesen, G. S. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m510863200 · Cited by 391
Active Repression of Antiapoptotic Gene Expression by RelA(p65) NF-κB
Campbell, K. J., Rocha, S., & Perkins, N. D. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00131-5 · Cited by 386
Bonnard, M. (2000) · The EMBO Journal · doi:10.1093/emboj/19.18.4976 · Cited by 381
Inhibition of TNF-induced apoptosis by NF-κB
Van Antwerp, D. J., Martin, S. J., Verma, I. M., & Green, D. R. (1998) · Trends in Cell Biology · doi:10.1016/s0962-8924(97)01215-4 · Cited by 367
Caspase-independent cell death in T lymphocytes
Jäättelä, M., & Tschopp, J. (2003) · Nature Immunology · doi:10.1038/ni0503-416 · Cited by 367
Reactive oxygen species mediate crosstalk between NF-κB and JNK
Nakano, H., Nakajima, A., Sakon-Komazawa, S., Piao, J.-H., Xue, X., & Okumura, K. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401830 · Cited by 366
Wu, H., & Lozano, G. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32128-2 · Cited by 361
NF-κB in cancer: a marked target
Lin, A., & Karin, M. (2003) · Seminars in Cancer Biology · doi:10.1016/s1044-579x(02)00128-1 · Cited by 355
The candidate tumour suppressor protein ING4 regulates brain tumour growth and angiogenesis
Garkavtsev, I., Kozin, S. V., Chernova, O., Xu, L., Winkler, F., Brown, E., Barnett, G. H., & Jain, R. K. (2004) · Nature · doi:10.1038/nature02329 · Cited by 353
Kang, S.-J., Wang, S., Hara, H., Peterson, E. P., Namura, S., Amin-Hanjani, S., Huang, Z., Srinivasan, A., Tomaselli, K. J., Thornberry, N. A., et al. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.149.3.613 · Cited by 324
Gadd45β mediates the NF-κB suppression of JNK signalling by targeting MKK7/JNKK2
Papa, S., Zazzeroni, F., Bubici, C., Jayawardena, S., Alvarez, K., Matsuda, S., Nguyen, D. U., Pham, C. G., Nelsbach, A. H., Melis, T., et al. (2004) · Nature Cell Biology · doi:10.1038/ncb1093 · Cited by 321
PIDD Mediates NF-κB Activation in Response to DNA Damage
Janssens, S., Tinel, A., Lippens, S., & Tschopp, J. (2005) · Cell · doi:10.1016/j.cell.2005.09.036 · Cited by 319
p53 stabilization is decreased upon NFκB activation
Tergaonkar, V., Pando, M., Vafa, O., Wahl, G., & Verma, I. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00068-5 · Cited by 313
Regulation of death receptor expression and TRAIL/Apo2L-induced apoptosis by NF-κB
Ravi, R., Bedi, G. C., Engstrom, L. W., Zeng, Q., Mookerjee, B., Gélinas, C., Fuchs, E. J., & Bedi, A. (2001) · Nature Cell Biology · doi:10.1038/35070096 · Cited by 312
Self-citationAbsence of tumor necrosis factor rescues RelA-deficient mice from embryonic lethality
Doi, T. S., Marino, M. W., Takahashi, T., Yoshida, T., Sakakura, T., Old, L. J., & Obata, Y. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.2994 · Cited by 306
Notch1 augments NF‐κB activity by facilitating its nuclear retention
Shin, H. M., Minter, L. M., Cho, O. H., Gottipati, S., Fauq, A. H., Golde, T. E., Sonenshein, G. E., & Osborne, B. A. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7600902 · Cited by 306
Death without caspases, caspases without death
Abraham, M. C., & Shaham, S. (2004) · Trends in Cell Biology · doi:10.1016/j.tcb.2004.03.002 · Cited by 304
Ventura, J.-J., Cogswell, P., Flavell, R. A., Baldwin, A. S., & Davis, R. J. (2004) · Genes & Development · doi:10.1101/gad.1223004 · Cited by 303
Inhibition of T–Cell Responses by Hepatic Stellate Cells Via B7–H1-Mediated T–Cell Apoptosis in Mice
Yu, M., Chen, C., Liang, X., Wang, L., Gandhi, C. R., Fung, J. J., Lu, L., & Qian, S. (2004) · Hepatology · doi:10.1002/hep.20488 · Cited by 301 · cited 1×
“…been linked to increased expression of the pro-death factors B7-H1 (PCD ligand 1, pdcd1), which induces apoptosis of T lymphocytes (Dong et al., 2002; Yu et al., 2004; Lee et al., 2005), and caspase-11, which can activate the death effector caspase-3 (Kang et al., 2000; Schauvliege et al., 2002).”
BackgroundBeyaert, R., Heyninck, K., & Van Huffel, S. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00404-4 · Cited by 301
Cytokines: Powerful Regulators of Glial Cell Activation
John, G. R., Lee, S. C., & Brosnan, C. F. (2003) · The Neuroscientist · doi:10.1177/1073858402239587 · Cited by 300
Physiological functions for brain NF-κB
Meffert, M. K., & Baltimore, D. (2005) · Trends in Neurosciences · doi:10.1016/j.tins.2004.11.002 · Cited by 293
Tanaka, H., Matsumura, I., Ezoe, S., Satoh, Y., Sakamaki, T., Albanese, C., Machii, T., Pestell, R. G., & Kanakura, Y. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00522-1 · Cited by 291
Stress-Responsive Protein Kinases in Redox-Regulated Apoptosis Signaling
Matsuzawa, A., & Ichijo, H. (2005) · Antioxidants & Redox Signaling · doi:10.1089/ars.2005.7.472 · Cited by 282
cFLIP regulation of lymphocyte activation and development
Budd, R. C., Yeh, W.-C., & Tschopp, J. (2006) · Nature Reviews Immunology · doi:10.1038/nri1787 · Cited by 280
Linking JNK signaling to NF-κB: a key to survival
Papa, S., Zazzeroni, F., Pham, C. G., Bubici, C., & Franzoso, G. (2004) · Journal of Cell Science · doi:10.1242/jcs.01483 · Cited by 276
Control of lymphocyte development by nuclear factor-κB
Siebenlist, U., Brown, K., & Claudio, E. (2005) · Nature Reviews Immunology · doi:10.1038/nri1629 · Cited by 272
Transcription factor NF-κB is constitutively activated in acute lymphoblastic leukemia cells
Kordes, U., Krappmann, D., Heissmeyer, V, Ludwig, W., & Scheidereit, C. (2000) · Leukemia · doi:10.1038/sj.leu.2401705 · Cited by 264
Hinz, M., Löser, P., Mathas, S., Krappmann, D., Dörken, B., & Scheidereit, C. (2001) · Blood · doi:10.1182/blood.v97.9.2798 · Cited by 261
Alcamo, E., Mizgerd, J. P., Horwitz, B. H., Bronson, R., Beg, A. A., Scott, M., Doerschuk, C. M., Hynes, R. O., & Baltimore, D. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.3.1592 · Cited by 259
NF-κB inhibition causes spontaneous apoptosis in Epstein–Barr virus-transformed lymphoblastoid cells
Cahir-McFarland, E. D., Davidson, D. M., Schauer, S. L., Duong, J., & Kieff, E. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.100119497 · Cited by 259
COMMD Proteins, a Novel Family of Structural and Functional Homologs of MURR1
Burstein, E., Hoberg, J. E., Wilkinson, A. S., Rumble, J. M., Csomos, R. A., Komarck, C. M., Maine, G. N., Wilkinson, J. C., Mayo, M. W., & Duckett, C. S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501928200 · Cited by 258
NFκB activation by Fas is mediated through FADD, caspase-8, and RIP and is inhibited by FLIP
Kreuz, S., Siegmund, D., Rumpf, J.-J., Samel, D., Leverkus, M., Janssen, O., Häcker, G., Dittrich-Breiholz, O., Kracht, M., Scheurich, P., et al. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200401036 · Cited by 257
Saccani, S., Marazzi, I., Beg, A. A., & Natoli, G. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040196 · Cited by 253
Kasibhatla, S., Genestier, L., & Green, D. R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.2.987 · Cited by 250
Grumont, R. J., Rourke, I. J., O'Reilly, L. A., Strasser, A., Miyake, K., Sha, W., & Gerondakis, S. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.5.663 · Cited by 249
Manipulation of the nuclear factor-κB pathway and the innate immune response by viruses
Hiscott, J., Nguyen, T.-L. A., Arguello, M., Nakhaei, P., & Paz, S. (2006) · Oncogene · doi:10.1038/sj.onc.1209941 · Cited by 247
Feuerhake, F. (2005) · Blood · doi:10.1182/blood-2004-12-4901 · Cited by 244
Rocha, S., Martin, A. M., Meek, D. W., & Perkins, N. D. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.13.4713-4727.2003 · Cited by 239
Collart, M. A., Baeuerle, P., & Vassalli, P. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.4.1498-1506.1990 · Cited by 235
Papa, S., Bubici, C., Zazzeroni, F., Pham, C. G., Kuntzen, C., Knabb, J. R., Dean, K., & Franzoso, G. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401865 · Cited by 235
Kaltschmidt, B., Ndiaye, D., Korte, M., Pothion, S., Arbibe, L., Prüllage, M., Pfeiffer, J., Lindecke, A., Staiger, V., Israël, A., et al. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.8.2936-2946.2006 · Cited by 228
Grossmann, M. (2000) · The EMBO Journal · doi:10.1093/emboj/19.23.6351 · Cited by 227
Vital functions for lethal caspases
Launay, S., Hermine, O., Fontenay, M., Kroemer, G., Solary, E., & Garrido, C. (2005) · Oncogene · doi:10.1038/sj.onc.1208524 · Cited by 226
Chan, H., Bartos, D. P., & Owen-Schaub, L. B. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.3.2098 · Cited by 225
A novel role for XIAP in copper homeostasis through regulation of MURR1
Burstein, E., Ganesh, L., Dick, R. D., van De Sluis, B., Wilkinson, J. C., Klomp, L. W., Wijmenga, C., Brewer, G. J., Nabel, G. J., & Duckett, C. S. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600031 · Cited by 222
NF-κB Inhibits Gammaherpesvirus Lytic Replication
Brown, H. J., Song, M. J., Deng, H., Wu, T.-T., Cheng, G., & Sun, R. (2003) · Journal of Virology · doi:10.1128/jvi.77.15.8532-8540.2003 · Cited by 219
Tsukahara, T., Kannagi, M., Ohashi, T., Kato, H., Arai, M., Nunez, G., Iwanaga, Y., Yamamoto, N., Ohtani, K., Nakamura, M., et al. (1999) · Journal of Virology · doi:10.1128/jvi.73.10.7981-7987.1999 · Cited by 213
Analysis of the activation status of Akt, NFκB, and Stat3 in human diffuse gliomas
Wang, H., Wang, H., Zhang, W., Huang, H. J., Liao, W. S. L., & Fuller, G. N. (2004) · Laboratory Investigation · doi:10.1038/labinvest.3700123 · Cited by 212
Tacconelli, A., Farina, A. R., Cappabianca, L., DeSantis, G., Tessitore, A., Vetuschi, A., Sferra, R., Rucci, N., Argenti, B., Screpanti, I., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.011 · Cited by 208
Glycogen Synthase Kinase 3β Functions To Specify Gene-Specific, NF-κB-Dependent Transcription
Steinbrecher, K. A., Wilson, W., Cogswell, P. C., & Baldwin, A. S. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.19.8444-8455.2005 · Cited by 205
Li, Q., Estepa, G., Memet, S., Israel, A., & Verma, I. M. (2000) · Genes & Development · doi:10.1101/gad.14.14.1729 · Cited by 203
Multiple mutations contribute to the oncogenicity of the retroviral oncoprotein v-Rel
Gilmore, T. D. (1999) · Oncogene · doi:10.1038/sj.onc.1203222 · Cited by 200
Regulation of T cell development by the deubiquitinating enzyme CYLD
Reiley, W. W., Zhang, M., Jin, W., Losiewicz, M., Donohue, K. B., Norbury, C. C., & Sun, S.-C. (2006) · Nature Immunology · doi:10.1038/ni1315 · Cited by 198
IκB-kinaseβ-dependent NF-κB activation provides radioprotection to the intestinal epithelium
Egan, L. J., Eckmann, L., Greten, F. R., Chae, S., Li, Z.-W., Myhre, G. M., Robine, S., Karin, M., & Kagnoff, M. F. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0306734101 · Cited by 192
p53- and Mdm2-Independent Repression of NF-κB Transactivation by the ARF Tumor Suppressor
Rocha, S., Campbell, K. J., & Perkins, N. D. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00223-5 · Cited by 189
NF-κB Is Essential for Induction of CYLD, the Negative Regulator of NF-κB
Jono, H., Lim, J. H., Chen, L.-F., Xu, H., Trompouki, E., Pan, Z. K., Mosialos, G., & Li, J.-D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406638200 · Cited by 179
Zheng, L., Bidère, N., Staudt, D., Cubre, A., Orenstein, J. M., Chan, F. K.-M., & Lenardo, M. J. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.9.3505-3513.2006 · Cited by 178
Matsui, K., Fine, A., Zhu, B., Marshak‐Rothstein, A., & Ju, S. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.7.3469 · Cited by 178
Matta, H., & Chaudhary, P. M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308016101 · Cited by 177
You, M., Ku, P.-T., Hrdličková, R., & Bose, H. R. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.12.7328 · Cited by 176
Oncogenic Signaling Pathways Activated in DMBA-Induced Mouse Mammary Tumors
Currier, N., Solomon, S. E., Demicco, E. G., Chang, D. L. F., Farago, M., Ying, H., Dominguez, I., Sonenshein, G. E., Cardiff, R. D., Xiao, Z.-X. J., et al. (2005) · Toxicologic Pathology · doi:10.1080/01926230500352226 · Cited by 174
Levenson, J. M., Choi, S., Lee, S.-Y., Cao, Y. A., Ahn, H. J., Worley, K. C., Pizzi, M., Liou, H.-C., & Sweatt, J. D. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.5646-03.2004 · Cited by 171
NF-κB is essential for the progression of KSHV- and EBV-infected lymphomas in vivo
Keller, S. A., Hernandez-Hopkins, D., Vider, J., Ponomarev, V., Hyjek, E., Schattner, E. J., & Cesarman, E. (2006) · Blood · doi:10.1182/blood-2005-07-2730 · Cited by 168
Kim, S.-J., Hwang, S.-G., Shin, D. Y., Kang, S.-S., & Chun, J.-S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202862200 · Cited by 168
Fridmacher, V., Kaltschmidt, B., Goudeau, B., Ndiaye, D., Rossi, F. M., Pfeiffer, J., Kaltschmidt, C., Israël, A., & Mémet, S. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-28-09403.2003 · Cited by 167 · cited 1×
“…its role in these physiological contexts seems to be independent of its effect on apoptosis, as RelA / TNF-R1-deficient mice or mice with targeted inhibition of NF-kB in the forebrain show normal CNS development and no defect in neuronal survival (Fridmacher et al., 2003; Meffert et al., 2003).”
BackgroundLuftig, M., Yasui, T., Soni, V., Kang, M.-S., Jacobson, N., Cahir-McFarland, E., Seed, B., & Kieff, E. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2237183100 · Cited by 167
Schwenzer, R., Siemienski, K., Liptay, S., Schubert, G., Peters, N., Scheurich, P., Schmid, R. M., & Wajant, H. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.27.19368 · Cited by 167
Kawakami, H., Tomita, M., Matsuda, T., Ohta, T., Tanaka, Y., Fujii, M., Hatano, M., Tokuhisa, T., & Mori, N. (2005) · International Journal of Cancer · doi:10.1002/ijc.20954 · Cited by 165
Addicted to Death: Invasive Cancer and the Immune Response to Unscheduled Cell Death
Zeh, H. J., & Lotze, M. T. (2005) · Journal of Immunotherapy · doi:10.1097/00002371-200501000-00001 · Cited by 164
Negative Regulation of JNK Signaling by the Tumor Suppressor CYLD
Reiley, W. W., Zhang, M., & Sun, S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m411049200 · Cited by 163
Regulation of NF‐κB and p53 through activation of ATR and Chk1 by the ARF tumour suppressor
Rocha, S., Garrett, M. D., Campbell, K. J., Schumm, K., & Perkins, N. D. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600608 · Cited by 162
Schauvliege, R., Vanrobaeys, J., Schotte, P., & Beyaert, R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207852200 · Cited by 161
NF-κB Activation by Camptothecin
Huang, T. T., Wuerzberger-Davis, S. M., Seufzer, B. J., Shumway, S. D., Kurama, T., Boothman, D. A., & Miyamoto, S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.13.9501 · Cited by 159
Lamsoul, I., Lodewick, J., Lebrun, S., Brasseur, R., Burny, A., Gaynor, R. B., & Bex, F. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.23.10391-10406.2005 · Cited by 155
Shishodia, S., Sethi, G., Konopleva, M. Y., Andreeff, M., & Aggarwal, B. B. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2044 · Cited by 147
Recruitment of IκBα to the hes1 promoter is associated with transcriptional repression
Aguilera, C. N., Hoya-Arias, R., Haegeman, G., Espinosa, L., & Bigas, A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404429101 · Cited by 143
IFN-gamma regulates the expression of B7-H1 in dermal fibroblast cells
Lee, S., SEO, S., Kim, B. C., Kim, C. D., Lee, J. H., Kang, J., Maeng, P. J., & Lim, J. (2005) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2005.06.008 · Cited by 138
Epstein–Barr virus latent membrane protein 1 activation of NF-κB through IRAK1 and TRAF6
Luftig, M. A., Prinarakis, E., Yasui, T., Tsichritzis, T., Cahir-McFarland, E. D., Inoue, J., Nakano, H., Mak, T. W., Yeh, W., Li, X., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2136756100 · Cited by 138
NF-κB RelA opposes epidermal proliferation driven by TNFR1 and JNK
Zhang, J. Y., Green, C. L., Tao, S., & Khavari, P. A. (2004) · Genes & Development · doi:10.1101/gad.1160904 · Cited by 135
Bcl-XL is up-regulated by HTLV-I and HTLV-II in vitro and in ex vivo ATLL samples
Nicot, C., Mahieux, R., Takemoto, S., & Franchini, G. (2000) · Blood · doi:10.1182/blood.v96.1.275 · Cited by 131
NF-κB transcription factors: critical regulators of hematopoiesis and neuronal survival
Denk, A., Wirth, T., & Baumann, B. (2000) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(00)00009-5 · Cited by 129
RelA repression of RelB activity induces selective gene activation downstream of TNF receptors
Jacque, É., Tchénio, T., Piton, G., Roméo, P., & Baud, V. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507342102 · Cited by 127
Nucleolar Sequestration of RelA (p65) Regulates NF-κB-Driven Transcription and Apoptosis
Stark, L. A., & Dunlop, M. G. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.14.5985-6004.2005 · Cited by 127
NF‐κB protects from the lysosomal pathway of cell death
Liu, N., Raja, S. M., Zazzeroni, F., Metkar, S. S., Shah, R., Zhang, M., Wang, Y., Brömme, D., Russin, W. A., Lee, J. C., et al. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg510 · Cited by 125
NF-κB-dependent MnSOD expression protects adenocarcinoma cells from TNF-α-induced apoptosis
Delhalle, S., Deregowski, V., Benoît, V., Merville, M., & Bours, V. (2002) · Oncogene · doi:10.1038/sj.onc.1205489 · Cited by 125
Bernard, D., Quatannens, B., Vandenbunder, B., & Abbadie, C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011183200 · Cited by 121
The Anti-Death Machinery in IKK/NF-κB Signaling
Luo, J., Kamata, H., & Karin, M. (2005) · Journal of Clinical Immunology · doi:10.1007/s10875-005-8217-6 · Cited by 119
Protein Methyltransferase 2 Inhibits NF-κB Function and Promotes Apoptosis
Lakshmanan, G., Yoshimoto, T., Moorthy, N. C., Akahata, W., Boehm, M., Nabel, E. G., & Nabel, G. J. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.10.3864-3874.2006 · Cited by 119
Zheng, Y., Ouaaz, F., Bruzzo, P., Singh, V., Gerondakis, S., & Beg, A. A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.8.4949 · Cited by 117
Cell survival and a Gadd45-factor deficiency
Amanullah, A., Azam, N., Balliet, A. G., Hollander, C. M., Hoffman‐Liebermann, B., Fornace, A. J., & Liebermann, D. A. (2003) · Nature · doi:10.1038/424741b · Cited by 116
Reawakening the cellular death program in neoplasia through the therapeutic blockade of IAP function
Wright, C. W., & Duckett, C. S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26251 · Cited by 115
Shou, Y., Li, N., Li, L., Borowitz, J. L., & Isom, G. E. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00880.x · Cited by 114
Baetu, T. M., Kwon, H., Sharma, S., Grandvaux, N., & Hiscott, J. B. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.6.3164 · Cited by 114
Kaur, S., Wang, F., Manickam, V., & Arsura, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505671200 · Cited by 112
EBV latent membrane protein-1 protects B cells from apoptosis by inhibition of BAX
Grimm, T. (2004) · Blood · doi:10.1182/blood-2004-07-2752 · Cited by 108
Rel/NF-κB/IκB signal transduction in the generation and treatment of human cancer
Gilmore, T. D., Gapuzan, M.-E. R., Kalaitzidis, D., & Starczynowski, D. T. (2002) · Cancer Letters · doi:10.1016/s0304-3835(01)00795-9 · Cited by 106
Neutralization of Smac/Diablo by Inhibitors of Apoptosis (IAPs)
Wilkinson, J. C., Wilkinson, A. S., Scott, F. L., Csomos, R. A., Salvesen, G. S., & Duckett, C. S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408655200 · Cited by 106
Ashikawa, K., Shishodia, S., Fokt, I., Priebe, W., & Aggarwal, B. B. (2003) · Biochemical Pharmacology · doi:10.1016/j.bcp.2003.08.039 · Cited by 105
Park, M., Jang, H. D., Lee, S. Y., Lee, K., & Kim, E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m304565200 · Cited by 103
Kasof, G. M., Lu, J. J., Liu, D., Speer, B. S., Mongan, K. N., Gomes, B. C., & Lorenzi, M. V. (2001) · Oncogene · doi:10.1038/sj.onc.1204985 · Cited by 96
Rivera-Walsh, I., Waterfield, M. R., Xiao, G., Fong, A., & Sun, S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100501200 · Cited by 96
Feuillard, J., Schuhmacher, M., Kohanna, S., Asso‐Bonnet, M., Ledeur, F., Joubert‐Caron, R., Bissières, P., Polack, A., Bornkamm, G. W., & Raphaël, M. (2000) · Blood · doi:10.1182/blood.v95.6.2068.2068 · Cited by 95
Ho, W. C., Dickson, K. M., & Barker, P. A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3494 · Cited by 95
Harhaj, E. W., Good, L., Xiao, G., & Sun, S. (1999) · Oncogene · doi:10.1038/sj.onc.1202405 · Cited by 89
Malignant transformation of primary chicken spleen cells by human transcription factor c-Rel
Gilmore, T. D., Cormier, C., Jean-Jacques, J., & Gapuzan, M.-E. R. (2001) · Oncogene · doi:10.1038/sj.onc.1204898 · Cited by 88
INK4 cell cycle inhibitors direct transcriptional inactivation of NF-κB
Wolff, B., & Naumann, M. (1999) · Oncogene · doi:10.1038/sj.onc.1202617 · Cited by 85
Gadd45β mediates the protective effects of CD40 costimulation against Fas-induced apoptosis
Zazzeroni, F., Papa, S., Algeciras-Schimnich, A., Alvarez, K., Melis, T., Bubici, C., Majewski, N., Hay, N., Smaele, E. D., Peter, M. E., et al. (2003) · Blood · doi:10.1182/blood-2003-03-0689 · Cited by 85
The interplay between innate and adaptive immunity regulates cancer development
de Visser, K. E., & Coussens, L. M. (2005) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-005-0702-5 · Cited by 83
Management of Patients with Recurrent Vulvovaginal Candidiasis
Sobel, J. D. (2003) · Drugs · doi:10.2165/00003495-200363110-00002 · Cited by 80
Wu, L., Nakano, H., & Wu, Z. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505903200 · Cited by 79
Cisplatin Mimics ARF Tumor Suppressor Regulation of RelA (p65) Nuclear Factor-κB Transactivation
Campbell, K. J., Witty, J., Rocha, S., & Perkins, N. D. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2234 · Cited by 79
Benezra, M., Chevallier, N., Morrison, D. J., MacLachlan, T. K., El‐Deiry, W. S., & Licht, J. D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303076200 · Cited by 78
Cited by
Introduction to NF-κB: players, pathways, perspectives
Gilmore, T. D. (2006) · Oncogene · doi:10.1038/sj.onc.1209954 · Cited by 2,222
Hayden, M. S., West, A. P., & Ghosh, S. (2006) · Oncogene · doi:10.1038/sj.onc.1209943 · Cited by 1,178
“NF-kB activation in response to TNF signaling induces expression of antiapoptotic genes such as cIAP1/2 and Bcl-XL (see Dutta et al., 2006).”
BackgroundIs NF-κB a good target for cancer therapy? Hopes and pitfalls
Baud, V., & Karin, M. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2781 · Cited by 1,061
Oxidative Stress and Lipid Peroxidation Products in Cancer Progression and Therapy
Barrera, G. (2012) · ISRN Oncology · doi:10.5402/2012/137289 · Cited by 820
Nuclear factor-κB and inhibitor of κB kinase pathways in oncogenic initiation and progression
Bassères, D. S., & Baldwin, A. S. (2006) · Oncogene · doi:10.1038/sj.onc.1209942 · Cited by 667
Metadata
- Authors
- Dutta, J., Fan, Y., Gupta, N., Fan, G., & Gélinas, C.
- Venue
- Oncogene
- Published
- 2006-10-30
- Volume
- 25
- Issue
- 51
- Pages
- 6800-6816
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2087952915
- Cited by
- 407
- References
- 225
- FWCI
- 12.36
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.